📣 Join our webinar 🖥️ today to hear about biomarkers 🧬 of #NRF2 activation and their role in fighting chronic diseases 💊

@benbedphar.bsky.social
#BenBedPhar #COST #NRF2 #redox

🔗 www.antiox.it/webinars2025...

Issue 13, October 2025 - BenBedPhar NRF2 in COST Action 20121 Our quarterly newsletter attempts to provide our latest news and also aims at becoming a forum for analysis of relevant topics on the field of NRF2 and provide comments to so...

📣 Newsletter alert: Check out the latest and sadly the last newsletter 🗞️ by @benbedphar.bsky.social COST Action CA20121 on recent cutting-edge #NRF2 research 🔬. Don't miss it 🎉
#BenBedPhar #EU #COSTaction #OxidativeStress

🔗 benbedphar.org/issue-13-oct...

Great energy at the COST Action BenBedPhar meeting in Istanbul! Researchers from across Europe discussed the latest on NRF2 and its translational potential in chronic diseases. Collaboration, science & progress at their best! 💡
#BenBedPhar #NRF2 #Science

A fantastic finale at Kadir Has Istanbul for the #BenBedPhar MC&Scientific Meeting. Delivered WG3 report, presented our new research, and chaired #NRF2 scientific session. Grateful for an incredible 4 years with this brilliant #COST Action community—a truly unique journey 🎉
@benbedphar.bsky.social

#BenBedPhar symposium took place in Galway @kasiawhysall.bsky.social where @mariaborjaa.bsky.social ECR REACT presented her work on #NRF2 and miRs in ageing!